Florida’s healthcare providers and their insurers are on the verge of a significant adjustment to the state’s medical malpractice landscape. For over three decades, a controversial provision within Florida’s medical malpractice laws limited who could file a wrongful death lawsuit involving non-economic damages, such as pain and suffering. With the passage of House Bill 6017

Medical needle“/ CC0 1.0

On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage List since 2022 because demand for the drug exceeded the available supply. Initially developed and utilized for treatment of Type 2 diabetes, semaglutide and other

In Florida, the corporate practice of dentistry is subject to stringent regulations designed to ensure that only licensed dentists have control over dental practices. This regulatory framework is crucial for maintaining the integrity of dental care and protecting patients from potential conflicts of interest that may arise when non-dentists are involved in the management of

E.J. Cyran, Partner at Fox Rothschild LLP, recently guested on PracticeCare®, a podcast devoted to help private practice owners stay private. The topic of the episode was identifying and avoiding landmines in agreements between vendors and private practices.

You can listen to the episode on Apple or Spotify here: https://marketvisorygroup.com/podcast/ej-cyran-on-landmines-in-vendor-agreements/

Whether you have a

As healthcare systems continue to adapt to an evolving landscape, the role of Advanced Practice Providers (APPs) has become increasingly important. APPs include nurse practitioners (NPs), clinical nurse specialists (CNSs), physician assistants (PAs), certified registered nurse anesthetists (CRNAs), anesthesia allergy assistants (AAs), and clinical pharmacist practitioners.  With an increasing demand for care, particularly in underserved

On December 11, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) published a Special Fraud Alert warning against suspect payment arrangements involving the Medicare Advantage (“MA”) program which could implicate the Federal Anti-Kickback Statute (“AKS”), the False Claims Act (“FCA”), and other health care fraud and abuse laws. These suspect

On April 26, 2024, the U.S. Department of Health and Human Services (“HHS”) issued new reproductive healthcare rules, which will go into effect on December 23, 2024. The underlying goals of these rules are to ensure individuals do not forego lawful health care when needed or withhold information from providers out of fear that sensitive

Introduction

California Assembly Bill 3129 (“AB 3129”) would have targeted private equity and hedge fund investment in health care entities specifically. It would have required private equity and hedge fund groups to provide 90 days pre-closing notice and obtain consent from the California Attorney General (“AG”) prior to a change of control or